Evaluating the NLRP3 inflammasome in chemotherapy-induced cognitive impairment: A multi-timepoint study of methotrexate and 5-fluorouracil in female rats
Publication date: 26 February 2027 Source: Behavioural Brain Research, Volume 518 Author(s): Olivia J. Haller, Laura M. Carr, Ines Semendric, Rebecca P. George, Alexandra L. Whittaker, Lyndsey E. Collins-Praino
Evaluating the NLRP3 inflammasome in chemotherapy-induced cognitive impairment: A multi-timepoint study of methotrexate and 5-fluorouracil in female rats. // Best Practice & Research Clinical Rheumatology. – URL: https://www.sciencedirect.com/science/article/pii/S0166432826005188?dgcid=rss_sd_all
Evaluating the NLRP3 inflammasome in chemotherapy-induced cognitive impairment: A multi-timepoint study of methotrexate and 5-fluorouracil in female rats. Best Practice & Research Clinical Rheumatology. https://www.sciencedirect.com/science/article/pii/S0166432826005188?dgcid=rss_sd_all
“Evaluating the NLRP3 inflammasome in chemotherapy-induced cognitive impairment: A multi-timepoint study of methotrexate and 5-fluorouracil in female rats.” Best Practice & Research Clinical Rheumatology.
@article{article4012,
title = {Evaluating the NLRP3 inflammasome in chemotherapy-induced cognitive impairment: A multi-timepoint study of methotrexate and 5-fluorouracil in female rats},
journal = {Best Practice \& Research Clinical Rheumatology},
url = {https://www.sciencedirect.com/science/article/pii/S0166432826005188?dgcid=rss_sd_all}
}